Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)
China
· Delayed Price · Currency is CNY 7.53
-0.01 (-0.13%)
Mar 10, 2026, 11:25 AM CST
SHE:002099 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 11,919 | 8,190 | 11,639 | 11,347 | 13,338 | 13,759 | Upgrade
|
| Market Cap Growth | 46.38% | -29.63% | 2.57% | -14.93% | -3.06% | 19.38% | Upgrade
|
| Enterprise Value | 11,711 | 7,823 | 11,071 | 10,831 | 11,966 | 12,433 | Upgrade
|
| Last Close Price | 7.53 | 5.16 | 7.19 | 6.97 | 8.07 | 8.30 | Upgrade
|
| PE Ratio | - | - | - | 128.93 | 140.06 | 43.04 | Upgrade
|
| Forward PE | - | 15.91 | 15.91 | 15.91 | 15.91 | 15.91 | Upgrade
|
| PS Ratio | 6.41 | 4.22 | 5.36 | 4.20 | 5.37 | 5.57 | Upgrade
|
| PB Ratio | 2.33 | 1.60 | 2.08 | 1.86 | 2.18 | 2.35 | Upgrade
|
| P/TBV Ratio | 2.83 | 1.94 | 2.60 | 2.34 | 2.74 | 3.01 | Upgrade
|
| P/FCF Ratio | - | 155.34 | 133.07 | - | - | 29.93 | Upgrade
|
| P/OCF Ratio | 227.91 | 46.85 | 48.39 | 97.74 | 130.31 | 25.77 | Upgrade
|
| EV/Sales Ratio | 6.29 | 4.04 | 5.10 | 4.01 | 4.82 | 5.03 | Upgrade
|
| EV/EBITDA Ratio | 70.75 | 37.89 | 119.42 | 25.20 | 29.45 | 18.32 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 110.36 | 102.12 | 29.46 | Upgrade
|
| EV/FCF Ratio | -252.21 | 148.38 | 126.58 | - | - | 27.05 | Upgrade
|
| Debt / Equity Ratio | 0.25 | 0.24 | 0.19 | 0.16 | 0.10 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 7.65 | 5.85 | 10.86 | 2.30 | 1.44 | 0.63 | Upgrade
|
| Debt / FCF Ratio | - | 23.40 | 12.06 | - | - | 0.94 | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | -0.06 | -0.06 | -0.08 | -0.20 | -0.26 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.23 | -1.59 | -3.94 | -1.14 | -3.06 | -2.27 | Upgrade
|
| Net Debt / FCF Ratio | 4.27 | -6.23 | -4.18 | 7.72 | 9.78 | -3.35 | Upgrade
|
| Asset Turnover | 0.25 | 0.26 | 0.27 | 0.33 | 0.33 | 0.36 | Upgrade
|
| Inventory Turnover | 1.84 | 2.12 | 2.20 | 2.01 | 1.96 | 1.82 | Upgrade
|
| Quick Ratio | 0.93 | 0.91 | 1.04 | 1.05 | 1.39 | 2.05 | Upgrade
|
| Current Ratio | 1.39 | 1.30 | 1.45 | 1.65 | 1.98 | 2.74 | Upgrade
|
| Return on Equity (ROE) | -6.42% | -6.22% | -7.20% | 1.41% | 1.57% | 5.52% | Upgrade
|
| Return on Assets (ROA) | -1.35% | -1.10% | -2.10% | 0.75% | 0.96% | 3.79% | Upgrade
|
| Return on Invested Capital (ROIC) | -3.26% | -2.62% | -4.93% | 1.60% | 1.95% | 7.90% | Upgrade
|
| Return on Capital Employed (ROCE) | -3.10% | -2.50% | -4.70% | 1.50% | 1.90% | 7.00% | Upgrade
|
| Earnings Yield | -2.81% | -4.03% | -3.61% | 0.78% | 0.71% | 2.32% | Upgrade
|
| FCF Yield | -0.39% | 0.64% | 0.75% | -0.56% | -0.95% | 3.34% | Upgrade
|
| Dividend Yield | - | - | - | 0.72% | 1.24% | 0.24% | Upgrade
|
| Payout Ratio | - | - | - | 222.06% | 56.13% | 149.54% | Upgrade
|
| Buyback Yield / Dilution | -48.34% | 2.66% | 8.22% | -10.91% | 0.71% | 0.45% | Upgrade
|
| Total Shareholder Return | -48.34% | 2.66% | 8.22% | -10.19% | 1.95% | 0.69% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.